1. Home
  2. DIN vs CMPX Comparison

DIN vs CMPX Comparison

Compare DIN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$34.15

Market Cap

399.8M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.04

Market Cap

371.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIN
CMPX
Founded
1958
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
399.8M
371.0M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
DIN
CMPX
Price
$34.15
$2.04
Analyst Decision
Hold
Strong Buy
Analyst Count
7
9
Target Price
$29.00
$14.57
AVG Volume (30 Days)
386.6K
4.2M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
2.78%
N/A
EPS Growth
N/A
N/A
EPS
0.57
N/A
Revenue
$879,300,000.00
N/A
Revenue This Year
$3.61
N/A
Revenue Next Year
$0.64
$934.41
P/E Ratio
$60.23
N/A
Revenue Growth
8.25
N/A
52 Week Low
$19.58
$1.61
52 Week High
$39.68
$6.88

Technical Indicators

Market Signals
Indicator
DIN
CMPX
Relative Strength Index (RSI) 69.38 39.97
Support Level $33.47 $1.68
Resistance Level $35.28 $2.47
Average True Range (ATR) 1.36 0.15
MACD 0.37 0.07
Stochastic Oscillator 85.59 27.12

Price Performance

Historical Comparison
DIN
CMPX

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: